TW201318641A - Powdery cosmetic - Google Patents

Powdery cosmetic Download PDF

Info

Publication number
TW201318641A
TW201318641A TW101140267A TW101140267A TW201318641A TW 201318641 A TW201318641 A TW 201318641A TW 101140267 A TW101140267 A TW 101140267A TW 101140267 A TW101140267 A TW 101140267A TW 201318641 A TW201318641 A TW 201318641A
Authority
TW
Taiwan
Prior art keywords
powder
ascorbic acid
glycoside
cosmetic
solution
Prior art date
Application number
TW101140267A
Other languages
Chinese (zh)
Inventor
Sayo Nomura
Seiji Kawai
Wataru Hoshino
Original Assignee
Kowa Co
Tokiwa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co, Tokiwa Corp filed Critical Kowa Co
Publication of TW201318641A publication Critical patent/TW201318641A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/022Powders; Compacted Powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Abstract

Provided are: a powdery cosmetic in which the stability of L-ascorbic acid 2-glucoside is maintained; and a method for producing the powdery cosmetic. A powdery cosmetic characterized by comprising a powdery L-ascorbic acid 2-glucoside composition that is produced by dissolving L-ascorbic acid 2-glucoside and a pH-adjusting agent in an aqueous solvent and then drying the resultant dissolution solution.

Description

粉末化妝料 Powder cosmetic

本發明係關於保有L-抗壞血酸2-糖苷之穩定性的粉末化妝料及其製造方法。 The present invention relates to a powder cosmetic which retains the stability of L-ascorbic acid 2-glycoside and a process for producing the same.

消費者對化妝料的需求逐年多樣化,除了基本的化妝效果之外,尚要求各種機能。因此,習知嘗試了於化妝料中調配美白成分或抗炎成分等,而提案有宣稱有各種藥理效果的化妝料。 Consumers' demand for cosmetics has been diversified year by year, and in addition to the basic makeup effects, various functions are required. Therefore, conventionally, it has been attempted to formulate whitening ingredients or anti-inflammatory ingredients in cosmetics, and proposals have been made for cosmetics having various pharmacological effects.

維他命C(抗壞血酸)由於具有皮膚之異常色素沉澱抑制作用,故屬於以預防斑點、雀斑等為目的而廣泛調配於化妝料中的美白成分。然而,其有對熱或氧化極弱、惰性化及容易分解的缺點。 Vitamin C (ascorbic acid) is a whitening ingredient which is widely formulated in cosmetics for the purpose of preventing spots and freckles, because it has an abnormal pigmentation inhibitory effect on the skin. However, it has the disadvantage of being extremely weak to heat or oxidation, inerting and easily decomposing.

關於維他命C之穩定化,已知有穩定型維他命C衍生物,其中,已知L-抗壞血酸2-糖苷係在0.2%溶液中依50℃保存了20天時,於pH4~9之區域中殘存率穩定為90%以上,且於生體內因酵素而被水解以產生維他命C,發揮維他命C之生理作用(非專利文獻1)。 Regarding the stabilization of vitamin C, a stable vitamin C derivative is known, and it is known that L-ascorbic acid 2-glycoside is retained in a region of pH 4 to 9 when stored in a 0.2% solution at 50 ° C for 20 days. The rate is stable to 90% or more, and it is hydrolyzed by the enzyme in the living body to produce vitamin C, and the physiological action of vitamin C is exerted (Non-Patent Document 1).

迄今,作為調配了L-抗壞血酸2-糖苷之化妝料,已報告有乳液或乳霜、美白用液劑、美白用面膜(專利文獻1、2)。 Heretofore, as a cosmetic formulated with L-ascorbic acid 2-glycoside, an emulsion, a cream, a whitening liquid, and a whitening mask have been reported (Patent Documents 1 and 2).

(專利文獻1)日本專利特開平3-135992號公報 (Patent Document 1) Japanese Patent Laid-Open No. Hei 3-135992

(專利文獻2)日本專利特開2011-93828號公報 (Patent Document 2) Japanese Patent Laid-Open Publication No. 2011-93828

(非專利文獻1)FRAGRANCE JOURNAL 1997-3 (Non-Patent Document 1) FRAGRANCE JOURNAL 1997-3

粉末化妝料由於可容易判別所塗佈之部位、可均勻塗佈,故為適合化妝料的劑型,一般係以雲母或滑石等之板狀粉體作為主體,配合化妝料之種類而適當混合成分後,予以粉碎而製造。 The powder cosmetic is a dosage form suitable for a cosmetic because it can be easily identified by coating the applied portion. Generally, a plate-like powder such as mica or talc is used as a main component, and the composition is appropriately mixed with the type of the cosmetic. After that, it is pulverized and manufactured.

然而,本發明者等人在進行了含有L-抗壞血酸2-糖苷之粉末化妝料的研究開始後,判明了依上述製造方法,即使藉pH調整劑調整pH為4~9,L-抗壞血酸2-糖苷之含量仍經時性地降低,而有保存穩定性的課題。 However, the present inventors have found that after the start of the research on the powder cosmetic containing L-ascorbic acid 2-glycoside, it is found that the pH is adjusted to 4 to 9, L-ascorbic acid 2- by the above-mentioned manufacturing method. The content of glycosides is still reduced with time, and there is a problem of preservation stability.

本發明有鑑於上述實情,而提供一種保有L-抗壞血酸2-糖苷之穩定性的粉末化妝料及其製造方法。 The present invention has been made in view of the above circumstances, and provides a powder cosmetic which retains the stability of L-ascorbic acid 2-glycoside and a method for producing the same.

本發明者等人經潛心研究,結果發現,在調製粉末化妝料時,將L-抗壞血酸2-糖苷與pH調整劑一起一次地溶解於水系溶媒後,將其乾燥並粉末化,則得到抑制了L-抗壞血酸2-糖苷之含量降低並保有穩定性的粉末化妝料,遂完成本發明。 As a result of intensive research, the present inventors have found that when a powder cosmetic is prepared, L-ascorbic acid 2-glycoside is dissolved in a water-based solvent together with a pH adjuster, and dried and powdered to suppress it. A powder cosmetic having a reduced content of L-ascorbic acid 2-glycoside and maintaining stability, and the present invention has been completed.

亦即,本發明提供一種粉末化妝料,其特徵為,含有將L-抗壞血酸2-糖苷及pH調整劑溶解於水系溶媒中,接著將溶解液乾燥而得到之L-抗壞血酸2-糖苷粉末組成物。 That is, the present invention provides a powder cosmetic comprising a L-ascorbic acid 2-glycoside powder composition obtained by dissolving L-ascorbic acid 2-glycoside and a pH adjuster in an aqueous solvent, followed by drying the solution. .

另外,本發明提供一種粉末化妝料之製造方法,其特徵為含有:將L-抗壞血酸2-糖苷及pH調整劑溶解於水系溶媒中的步驟;與藉由將所得之溶解液乾燥,而製造L-抗壞血酸2-糖苷粉末組成物的步驟。 Further, the present invention provides a method for producing a powder cosmetic comprising the steps of: dissolving L-ascorbic acid 2-glycoside and a pH adjuster in an aqueous solvent; and drying the obtained solution to produce L - a step of the ascorbic acid 2-glycoside powder composition.

根據本發明,由於可提高L-抗壞血酸2-糖苷之經時穩定性,故可提供能有效發揮美白效果的粉末化妝料。 According to the present invention, since the stability over time of L-ascorbic acid 2-glycoside can be improved, a powder cosmetic which can effectively exhibit the whitening effect can be provided.

本發明之粉末化妝料係含有L-抗壞血酸2-糖苷粉末組成物。該L-抗壞血酸2-糖苷粉末組成物係將L-抗壞血酸2-糖苷與pH調整劑溶解於水系溶媒中後,進行乾燥使水系溶媒揮發(蒸散),或將L-抗壞血酸2-糖苷與pH調整劑溶解於水系溶媒中後,進一步使溶解液分散於後述粉末之一部分或全部後,進行乾燥使水系溶媒揮發(蒸散)而製造。 The powder cosmetic of the present invention contains a L-ascorbic acid 2-glycoside powder composition. The L-ascorbic acid 2-glycoside powder composition is prepared by dissolving L-ascorbic acid 2-glycoside and a pH adjuster in an aqueous solvent, and then drying the aqueous solvent to evaporate (evaporate) or adjusting L-ascorbic acid 2-glycoside with pH. After the agent is dissolved in the aqueous solvent, the solution is further dispersed in a part or all of the powder described later, and then dried to volatilize (evaporate) the aqueous solvent to produce.

本發明所使用之L-抗壞血酸2-糖苷,化學名為2-O-α-D-葡萄哌喃糖苷-L-抗壞血酸,分子式C12H18O11所示之化合物,具有於L-抗壞血酸之2位之羥基上鍵結了葡萄糖的構造。 L-ascorbic acid 2-glycoside used in the present invention, chemical name: 2-O-α-D-glucopyranoside-L-ascorbic acid, a compound of the formula C 12 H 18 O 11 , having L-ascorbic acid The structure of glucose is bonded to the hydroxyl group at position 2.

L-抗壞血酸2-糖苷可依公知方法進行製造,亦可使用市售物。作為市售物,有如AA2G(一丸PHARCOS股份有限公司)、AS-G(TECHNOBLE股份有限公司)等。 L-ascorbic acid 2-glycoside can be produced by a known method, and a commercially available product can also be used. As a commercial item, there are, for example, AA2G (Yumaru PHARCOS Co., Ltd.), AS-G (TECHNOBLE Co., Ltd.), and the like.

作為本發明所使用之pH調整劑,可舉例如檸檬酸、蘋果 酸、琥珀酸、反丁烯二酸、乳酸、酒石酸、醋酸等之有機酸,鹽酸、硫酸、磷酸等之無機酸,或此等之鹽、氫氧化鈉、氫氧化鉀、氫氧化鈣、氫氧化鎂、氨水等之無機鹼,2-胺基-2-甲基-1-丙醇、二異丙醇胺、三異丙醇胺、三乙醇胺、單乙醇胺等之有機鹼,精胺酸、離胺酸、組胺酸、鳥胺酸等之鹼性胺基酸等。此等可使用1種或組合2種以上使用。其中,由提升L-抗壞血酸2-糖苷之穩定性的觀點而言,較佳為氫氧化鈉、氫氧化鉀、2-胺基-2-甲基-1-丙醇、三乙醇胺、精胺酸、組胺酸、鳥胺酸,更佳為氫氧化鉀、2-胺基-2-甲基-1-丙醇、精胺酸。 The pH adjuster used in the present invention may, for example, be citric acid or apple. Organic acids such as acid, succinic acid, fumaric acid, lactic acid, tartaric acid, acetic acid, inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, etc., or such salts, sodium hydroxide, potassium hydroxide, calcium hydroxide, hydrogen An inorganic base such as magnesium oxide or ammonia water, an organic base such as 2-amino-2-methyl-1-propanol, diisopropanolamine, triisopropanolamine, triethanolamine or monoethanolamine, arginine, A basic amino acid such as lysine, histidine or ornithine. These may be used alone or in combination of two or more. Among them, from the viewpoint of improving the stability of L-ascorbic acid 2-glycoside, sodium hydroxide, potassium hydroxide, 2-amino-2-methyl-1-propanol, triethanolamine, arginine is preferred. And histidine, ornithine, more preferably potassium hydroxide, 2-amino-2-methyl-1-propanol, arginine.

pH調整劑之調配量,係由提升L-抗壞血酸2-糖苷之穩定性的觀點而言,較佳係調配使於水系溶媒中溶解了L-抗壞血酸2-糖苷與pH調整劑之液的pH(25℃)成為5~8、特佳6~7的量。 The pH adjustment agent is preferably formulated to improve the pH of the liquid of the L-ascorbic acid 2-glycoside and the pH adjuster in the aqueous solvent from the viewpoint of improving the stability of the L-ascorbic acid 2-glycoside. 25 ° C) is 5 to 8, and particularly good 6 to 7.

作為本發明所使用之水系溶媒,可舉例如水或有機溶劑的水溶液。作為有機溶媒,若為與水均勻混合者則無特別限定,較佳為例如甲醇、乙醇、丙醇等之低級醇。有機溶媒於水溶液中之水的比例,係相對於總溶媒量,較佳為90質量%以上、更佳95質量%以上、特佳97質量%以上。 The aqueous solvent used in the present invention may, for example, be an aqueous solution of water or an organic solvent. The organic solvent is not particularly limited as long as it is uniformly mixed with water, and is preferably a lower alcohol such as methanol, ethanol or propanol. The ratio of the water of the organic solvent in the aqueous solution is preferably 90% by mass or more, more preferably 95% by mass or more, and particularly preferably 97% by mass or more based on the total amount of the solvent.

其中,由L-抗壞血酸2-糖苷之溶解性的觀點而言,較佳為水。水可為蒸餾水、離子交換水、精製水之任一種。 Among them, water is preferred from the viewpoint of solubility of L-ascorbic acid 2-glycoside. The water may be any of distilled water, ion exchange water, and purified water.

水系溶媒之使用量,係由L-抗壞血酸2-糖苷之溶解性、 工業生產性的觀點而言,在僅溶解L-抗壞血酸2-糖苷與pH調整劑的情況,係相對於固形份1g,較佳為0.5mL以上、更佳0.7mL以上、特佳1mL以上。於此,所謂固形份,係指L-抗壞血酸2-糖苷與pH調整劑(其中,水分除外)。又,在進一步加入粉體而使其分散於溶解液中時,水系溶媒與粉體的量係以質量比計,較佳為1:2~1:30、更佳1:3~1:20、特佳1:3~1:10。 The amount of water-based solvent used is the solubility of L-ascorbic acid 2-glycoside, From the viewpoint of industrial productivity, when only L-ascorbic acid 2-glycoside and a pH adjuster are dissolved, it is preferably 0.5 mL or more, more preferably 0.7 mL or more, and particularly preferably 1 mL or more, relative to 1 g of the solid content. Here, the solid content means L-ascorbic acid 2-glycoside and a pH adjuster (excluding moisture). Further, when the powder is further added and dispersed in the solution, the amount of the aqueous solvent and the powder is preferably from 1:2 to 1:30, more preferably from 1:3 to 1:20. , especially good 1:3~1:10.

在將L-抗壞血酸2-糖苷與pH調整劑溶解於水系溶媒時的溫度,並無特別限定,較佳為25~70℃、更佳40~70℃。 The temperature at which the L-ascorbic acid 2-glycoside and the pH adjuster are dissolved in the aqueous solvent is not particularly limited, but is preferably 25 to 70 ° C, more preferably 40 to 70 ° C.

將溶解了L-抗壞血酸2-糖苷與pH調整劑之溶解劑進行乾燥的方法,並無特別限制,可應用公知方法。可舉例如熱乾燥(熱風乾燥、室溫乾燥、傳熱乾燥)、噴霧乾燥、流動乾燥、凍結乾燥、減壓乾燥等。此等之中,由工業生產性的觀點而言,較佳為熱乾燥,更佳為熱風乾燥。乾燥後,視需要亦可進行分級、造粒、粉碎等。 The method of drying the dissolving agent in which the L-ascorbic acid 2-glycoside and the pH adjuster are dissolved is not particularly limited, and a known method can be applied. For example, thermal drying (hot air drying, room temperature drying, heat transfer drying), spray drying, flow drying, freeze drying, reduced pressure drying, and the like can be given. Among these, from the viewpoint of industrial productivity, it is preferably thermally dried, and more preferably hot air dried. After drying, classification, granulation, pulverization, and the like may be carried out as needed.

加熱時之乾燥溫度,係由乾燥時間縮短的觀點、L-抗壞血酸2-糖苷之穩定性的觀點而言,較佳為25~80℃、更佳40~70℃。又,乾燥時間較佳為1~24小時、更佳5~12小時。 The drying temperature at the time of heating is preferably from 25 to 80 ° C, more preferably from 40 to 70 ° C from the viewpoint of shortening the drying time and the stability of the L-ascorbic acid 2-glycoside. Further, the drying time is preferably from 1 to 24 hours, more preferably from 5 to 12 hours.

藉由於粉末化妝料中含有如此所得之L-抗壞血酸2-糖苷粉末組成物,則即使在曝露於高溫高濕度條件下的情況,仍保有L-抗壞血酸2-糖苷的穩定性,可作成經時性之L-抗壞血酸2-糖苷含量之降低較少的粉末化妝料。 By containing the L-ascorbic acid 2-glycoside powder composition thus obtained in the powder cosmetic, the stability of the L-ascorbic acid 2-glycoside can be maintained even when exposed to high temperature and high humidity conditions, and can be made into a time-dependent property. A powder cosmetic having a reduced reduction in the content of L-ascorbic acid 2-glycoside.

本發明中所謂粉末化妝料,係指以粉體為主骨架的化妝料,可為於室溫下具有流動性之粉末狀、成型為粉體的固形狀的任一種。作為化妝料之種類並無特別限定,可舉例如粉底、白粉、遮瑕劑、打亮、腮紅、眼影等之化妝料或身體粉等。 The powder cosmetic in the present invention refers to a cosmetic having a powder as a main skeleton, and may be any powder having a fluidity at room temperature and a solid shape molded into a powder. The type of the cosmetic material is not particularly limited, and examples thereof include a foundation, a white powder, a concealer, a cosmetic such as brightening, blushing, and eye shadow, or a body powder.

作為本發明之粉末化妝料中所使用的粉體,若為該技術領域中通常使用者即可,可舉例如無機粉體、有機粉體、此等之複合體等。粉體之形狀、粒徑等並無特別限定。 The powder to be used in the powder cosmetic of the present invention may be a general user in the technical field, and examples thereof include an inorganic powder, an organic powder, and the like. The shape, particle diameter, and the like of the powder are not particularly limited.

作為無機粉體,可舉例如雲母、滑石、二氧化矽、絹雲母、合成金雲母、高嶺土、氧化鈦、氧化鋅、微粒子氧化鈦、氧化鎂、氧化鋯、碳酸鈣、碳酸鎂、矽酸鋁、矽酸鎂、硫酸鋇、硫酸鎂、硬脂酸鎂、氮化硼、鐵丹、黃氧化鐵、黑氧化鐵、碳黑、錳紫、群青、紺青、雲母鈦、鐵丹被覆雲母鈦、玻璃末等。 Examples of the inorganic powder include mica, talc, cerium oxide, sericite, synthetic phlogopite, kaolin, titanium oxide, zinc oxide, fine particle titanium oxide, magnesium oxide, zirconium oxide, calcium carbonate, magnesium carbonate, and aluminum citrate. , magnesium citrate, barium sulfate, magnesium sulfate, magnesium stearate, boron nitride, iron oxide, yellow iron oxide, black iron oxide, carbon black, manganese violet, ultramarine blue, indigo, mica titanium, iron oxide coated mica titanium, The end of the glass, etc.

作為有機體,可舉例如尼龍、聚苯乙烯、聚烯烴、聚矽氧樹脂、氟樹脂、聚酯、聚醯胺、纖維素、銀粉等之高分子化合物;紅色104號、紅色106號、紅色201號、紅色202號、紅色204號、紅色226號、黃色4號、黃色5號、黃色401號、藍色1號、綠色3號等之有機顏料等。 Examples of the organic substance include high molecular compounds such as nylon, polystyrene, polyolefin, polyoxyxylene resin, fluororesin, polyester, polyamide, cellulose, and silver powder; red 104, red 106, and red 201 Organic pigments such as No., Red No. 202, Red No. 204, Red No. 226, Yellow No. 4, Yellow No. 5, Yellow No. 401, Blue No. 1, and Green No. 3.

作為複合體之粉體,可舉例如於球狀尼龍粉體塗敷了微粒子氧化鈦者、於球狀聚矽氧樹脂粉體塗敷了板狀雲母者等。 The powder of the composite body may be, for example, a case where a spherical nylon powder is coated with fine particles of titanium oxide, and a spherical polyoxyn resin powder is coated with a plate-shaped mica.

此等可單獨使用或組合2種以上而使用。 These can be used individually or in combination of 2 or more types.

再者,亦可使用將上述粉體之表面之一部分或全部,藉常法進行了親水處理或疏水處理的粉體。親水處理可例如使用親水性高分子、界面活性劑、二氧化矽、氧化鋁等之無機化合物等之親水處理劑而進行。又,疏水處理可使用聚矽氧油或其衍生物、脂肪酸鹽、氟化合物、胺基酸化合物等之疏水處理劑而進行。 Further, a powder in which part or all of the surface of the above-mentioned powder is subjected to hydrophilic treatment or hydrophobic treatment by a usual method may be used. The hydrophilic treatment can be carried out, for example, by using a hydrophilic treatment agent such as a hydrophilic polymer, a surfactant, an inorganic compound such as ceria or alumina. Further, the hydrophobic treatment can be carried out using a hydrophobic treatment agent such as a polyoxygenated oil or a derivative thereof, a fatty acid salt, a fluorine compound or an amino acid compound.

本發明中,由提升L-抗壞血酸2-糖苷之穩定性的觀點而言,粉體較佳係使用經疏水處理的粉體,較佳為使用例如甲基聚矽氧烷處理滑石、甲基聚矽氧烷處理絹雲母、甲基氫聚矽氧烷處理滑石、甲基氫聚矽氧烷處理絹雲母等。 In the present invention, from the viewpoint of improving the stability of L-ascorbic acid 2-glycoside, the powder is preferably a hydrophobically treated powder, preferably treated with, for example, methyl polyoxyalkylene, talc, methyl poly The siloxane treatment of sericite, methyl hydrogen polyoxyalkylene treatment of talc, methyl hydrogen polyoxyalkylene treatment of sericite, and the like.

粉體之含量係視其種類而相異,但通常相對於粉末化妝料全量,較佳為60質量%以上、更佳80質量%以上。 The content of the powder varies depending on the type thereof, but is usually 60% by mass or more, and more preferably 80% by mass or more based on the total amount of the powder cosmetic.

另外,粉體亦可依在製造L-抗壞血酸2-糖苷粉末組成物之步驟的階段,使於水系溶媒中溶解了L-抗壞血酸2-糖苷與pH調整劑之溶解液載持於粉末化妝料中所使用之粉體之一部分或全部的目的而使用。 Further, the powder may be carried in a powder cosmetic in a stage in which the L-ascorbic acid 2-glycoside powder composition is produced in a step of dissolving L-ascorbic acid 2-glycoside and a pH adjusting agent in an aqueous solvent. It is used for the purpose of part or all of the powder used.

在載持溶解液時之粉體的量,係由L-抗壞血酸2-糖苷之穩定性、工業生產性的觀點而言,水系溶媒量與粉體之量以質量比計,較佳為1:2~1:30、更佳1:3~1:20、特佳1:3~1:10。 The amount of the powder at the time of carrying the solution is preferably from the viewpoint of stability of L-ascorbic acid 2-glycoside and industrial productivity, and the amount of the aqueous solvent to the amount of the powder is preferably 1: 2~1:30, better 1:3~1:20, especially good 1:3~1:10.

本發明之粉末化妝料中,除了上述成分之外,在不損及本發明效果的範圍內,可適當調配例如對氧基苯甲酸甲酯、對 氧基苯甲酸乙酯、對氧基苯甲酸丙酯、對氧基苯甲酸丁酯等之防腐劑;陰離子界面活性劑、陽離子界面活性劑、非離子界面活性劑等之界面活性劑;動植物油、烴油、酯油、聚矽氧油、氟油、醚油等之液狀油劑;動物性蠟、植物性蠟、礦物性蠟、合成蠟等之固體狀油劑;甘油、1,3-丁二醇、聚乙二醇等之多元醇類;香料;玻尿酸、膠原蛋白、腦醯胺、蜂王膠等之保濕劑;維他命E類等之維他命等的1種或2種以上。 In the powder cosmetic of the present invention, in addition to the above components, for example, methyl p-oxybenzoate may be appropriately blended, and in the range which does not impair the effects of the present invention, Preservatives such as ethyl oxybenzoate, propyl p-oxybenzoate, butyl p-oxybenzoate; surfactants such as anionic surfactants, cationic surfactants, nonionic surfactants; animal and vegetable oils a liquid oil agent such as a hydrocarbon oil, an ester oil, a polyoxygenated oil, a fluorine oil or an ether oil; a solid oil such as an animal wax, a vegetable wax, a mineral wax or a synthetic wax; glycerin, 1, 3 - Polyols such as butanediol and polyethylene glycol; perfume; hyaluronic acid such as hyaluronic acid, collagen, ceramide, and royal jelly; and one or more types of vitamins such as vitamin E.

另外,本發明之中,亦可適當調配L-抗壞血酸2-糖苷以外之美白成分、甘草酸或其鹽等之抗炎症劑、亞甲基雙苯并三唑基四甲基丁基酚、對甲氧基桂皮酸2-乙基己酯等之紫外線防禦劑等的1種或2種以上。 Further, in the present invention, an anti-inflammatory agent such as a whitening component other than L-ascorbic acid 2-glycoside, glycyrrhizic acid or a salt thereof, methylenebisbenzotriazolyl tetramethylbutylphenol, or the like may be appropriately formulated. One or two or more kinds of ultraviolet protection agents such as 2-ethylhexyl methoxycinnamate.

本發明之粉末化妝料可使用L-抗壞血酸2-糖苷粉末組成物依常法進行製造。亦即,將L-抗壞血酸2-糖苷粉末組成物、粉體及視需要之其他添加劑等,以混合器均勻混合,藉錘磨進行粉碎而製造。所得粉末化妝料的粒徑為300μm以下、特佳150μm以下。 The powder cosmetic of the present invention can be produced by a usual method using an L-ascorbic acid 2-glycoside powder composition. In other words, the L-ascorbic acid 2-glycoside powder composition, the powder, and other additives as needed are uniformly mixed by a mixer and pulverized by a hammer mill. The particle size of the obtained powder cosmetic is 300 μm or less, and particularly preferably 150 μm or less.

本發明中,L-抗壞血酸2-糖苷之含量並無特別限制,由美白效果、安全性、使用感的觀點而言,係相對於粉末化妝料全量,較佳為0.1~10質量%、更佳1~5質量%。 In the present invention, the content of L-ascorbic acid 2-glycoside is not particularly limited, and is preferably from 0.1 to 10% by mass, more preferably from 0.1% to 10% by mass, based on the total amount of the powder cosmetic, from the viewpoint of whitening effect, safety, and feeling of use. 1 to 5 mass%.

另外,本發明之粉末化妝料中之L-抗壞血酸2-糖苷的殘存率,例如於40℃相對濕度75%之條件下保存了3~6個月 時,至少為80%以上、較佳85%以上、更佳90%以上。 Further, the residual ratio of L-ascorbic acid 2-glycoside in the powder cosmetic of the present invention is, for example, stored at a relative humidity of 75% at 40 ° C for 3 to 6 months. At least 80% or more, preferably 85% or more, more preferably 90% or more.

另外,本發明粉末化妝料之pH(25℃,10w/v%水溶液)係由保存穩定性的觀點而言,較佳為4~10。 Further, the pH (25 ° C, 10 w/v% aqueous solution) of the powder cosmetic of the present invention is preferably 4 to 10 from the viewpoint of storage stability.

作為收納本發明粉末化妝料的容器,可使用塑膠製容器、玻璃製容器、金屬製容器等。 As the container for accommodating the powder cosmetic of the present invention, a plastic container, a glass container, a metal container or the like can be used.

本發明之粉末化妝料在進一步提升L-抗壞血酸2-糖苷之經時穩定性的目的下,亦可於容器內與乾燥劑共存。 The powder cosmetic of the present invention can also coexist with a desiccant in a container for the purpose of further improving the stability of L-ascorbic acid 2-glycoside over time.

接著說明本發明之態樣及較佳實施態樣。 Next, the aspects and preferred embodiments of the present invention will be described.

<1>一種粉末化妝料,係含有於水系溶媒中溶解L-抗壞血酸2-糖苷與pH調整劑,接著將溶解液乾燥而獲得之L-抗壞血酸2-糖苷粉末組成物。 <1> A powder cosmetic comprising a L-ascorbic acid 2-glycoside powder composition obtained by dissolving L-ascorbic acid 2-glycoside in a water-based solvent and a pH adjuster, followed by drying the solution.

<2>如上述<1>之粉末化妝料,其中,L-抗壞血酸2-糖苷粉末組成物係將已溶解L-抗壞血酸2-糖苷與pH調整劑的溶解液,進一步分散於粉體中後再進行乾燥者。 <2> The powder cosmetic according to the above <1>, wherein the L-ascorbic acid 2-glycoside powder composition is a solution in which the L-ascorbic acid 2-glycoside and the pH adjuster are dissolved, and further dispersed in the powder. Dryer.

<3>如上述<2>之粉末化妝料,其中,粉體為選自無機粉體、有機粉體及此等之複合體的1種或2種以上之粉體。 <3> The powder cosmetic according to the above <2>, wherein the powder is one or more powders selected from the group consisting of inorganic powders, organic powders, and the like.

<4>如上述<2>之粉末化妝料,其中,粉體為經疏水處理的粉體。 <4> The powder cosmetic according to the above <2>, wherein the powder is a hydrophobically treated powder.

<5>如上述<2>~<4>中任一項之粉末化妝料,其中,水系溶媒量與粉體之量的質量比為1:2~1:30,較佳1:3~1:20,更佳1:3~1:10。 <5> The powder cosmetic according to any one of <2> to <4> wherein the mass ratio of the amount of the aqueous solvent to the amount of the powder is from 1:2 to 1:30, preferably from 1:3 to 1. :20, better 1:3~1:10.

<6>如上述<1>~<5>中任一項之粉末化妝料,其中,pH調 整劑為選自檸檬酸、蘋果酸、琥珀酸、反丁烯二酸、乳酸、酒石酸、醋酸、鹽酸、硫酸、磷酸、或此等之鹽、氫氧化鈉、氫氧化鉀、氫氧化鈣、氫氧化鎂、氨水、2-胺基-2-甲基-1-丙醇、二異丙醇胺、三異丙醇胺、三乙醇胺、單乙醇胺、精胺酸、離胺酸、組胺酸、鳥胺酸之1種或2種以上;較佳為選自氫氧化鈉、氫氧化鉀、2-胺基-2-甲基-1-丙醇、三乙醇胺、精胺酸、組胺酸、鳥胺酸之1種或2種以上;更佳為選自氫氧化鉀、2-胺基-2-甲基-1-丙醇、精胺酸之1種或2種以上。 <6> The powder cosmetic according to any one of <1> to <5> above, wherein the pH is adjusted The whole agent is selected from the group consisting of citric acid, malic acid, succinic acid, fumaric acid, lactic acid, tartaric acid, acetic acid, hydrochloric acid, sulfuric acid, phosphoric acid, or the like, sodium hydroxide, potassium hydroxide, calcium hydroxide, Magnesium hydroxide, ammonia, 2-amino-2-methyl-1-propanol, diisopropanolamine, triisopropanolamine, triethanolamine, monoethanolamine, arginine, lysine, histidine And one or more of ornithine; preferably selected from the group consisting of sodium hydroxide, potassium hydroxide, 2-amino-2-methyl-1-propanol, triethanolamine, arginine, histidine And one or more of ornithine; more preferably one or more selected from the group consisting of potassium hydroxide, 2-amino-2-methyl-1-propanol, and arginine.

<7>如上述<1>~<6>中任一項之粉末化妝料,其中,pH調整劑之調配量係使於水系溶媒中溶解了L-抗壞血酸2-糖苷與pH調整劑之液的pH(25℃)成為5~8之量、特佳成為pH6~7的量。 The powder cosmetic according to any one of the above-mentioned items, wherein the pH adjusting agent is prepared by dissolving a liquid of L-ascorbic acid 2-glycoside and a pH adjuster in an aqueous solvent. The pH (25 ° C) is 5 to 8 and particularly preferably pH 6 to 7.

<8>如上述<1>~<7>中任一項之粉末化妝料,其中,水系溶媒為水或有機溶媒之水溶液,較佳為水或低級醇之水溶液,更佳為水。 The powder cosmetic according to any one of the above-mentioned items, wherein the aqueous solvent is an aqueous solution of water or an organic solvent, preferably an aqueous solution of water or a lower alcohol, more preferably water.

<9>一種粉末化妝料之製造方法,其特徵為含有:將L-抗壞血酸2-糖苷及pH調整劑溶解於水系溶媒中的步驟;與藉由將所得之溶解液乾燥,而製造L-抗壞血酸2-糖苷粉末組成物的步驟。 <9> A method for producing a powder cosmetic comprising: a step of dissolving L-ascorbic acid 2-glycoside and a pH adjuster in an aqueous solvent; and drying the obtained solution to produce L-ascorbic acid The step of the 2-glycoside powder composition.

<10>一種粉末化妝料之製造方法,其特徵為含有:將L-抗壞血酸2-糖苷及pH調整劑溶解於水系溶媒中的步驟;將 所得溶解液分散於粉體中的步驟;與藉由將所得之含有溶解液之粉體乾燥,而製造L-抗壞血酸2-糖苷粉末組成物的步驟。 <10> A method for producing a powder cosmetic comprising the step of dissolving L-ascorbic acid 2-glycoside and a pH adjuster in an aqueous solvent; The step of dispersing the obtained solution in the powder; and the step of producing the L-ascorbic acid 2-glycoside powder composition by drying the obtained powder containing the solution.

(實施例) (Example)

以下,列舉實施例具體說明本發明,但本發明並不限定於此等。 Hereinafter, the present invention will be specifically described by way of examples, but the present invention is not limited thereto.

(實施例1) (Example 1)

將L-抗壞血酸2-糖苷(一丸PHARCOS股份有限公司,以下皆同)2g、L-精胺酸(純正化學股份有限公司,以下皆同)1.032g於室溫下混合至精製水2g,予以溶解。接著將滑石(角八魚鱗箔股份有限公司,以下皆同)20g添加至先前之溶解液中並均勻混合後,以60℃乾燥10小時,得到23.032g之L-抗壞血酸2-糖苷粉末組成物。 2 g of L-ascorbic acid 2-glycoside (one pill PHARCOS Co., Ltd., the following), and 1.032 g of L-arginine (Pure Chemical Co., Ltd., the following) were mixed at room temperature to 2 g of purified water to dissolve . Then, 20 g of talc (Cornerfish Co., Ltd., the following is the same) was added to the previous solution and uniformly mixed, and then dried at 60 ° C for 10 hours to obtain 23.032 g of an L-ascorbic acid 2-glycoside powder composition.

(實施例2) (Example 2)

除了取代滑石而使用甲基聚矽氧烷處理滑石(三好化成股份有限公司,以下皆同)20g以外,其餘與實施例1同樣地進行而調製溶解液後,以60℃乾燥10小時,得到23.032g之L-抗壞血酸2-糖苷粉末組成物。 The solution was prepared in the same manner as in Example 1 except that 20 g of talc (Sankyo Chemical Co., Ltd., the same applies hereinafter) was used in place of talc, and then dried at 60 ° C for 10 hours to obtain 23.032. g-L-ascorbic acid 2-glycoside powder composition.

(實施例3) (Example 3)

除了使用L-精胺酸1.022g以外,其餘與實施例2同樣地進行而調製溶解液後,以60℃乾燥10小時,得到23.022g之L-抗壞血酸2-糖苷粉末組成物。 The solution was prepared in the same manner as in Example 2 except that 1.022 g of L-arginine was used, and then dried at 60 ° C for 10 hours to obtain 23.022 g of an L-ascorbic acid 2-glycoside powder composition.

(實施例4) (Example 4)

除了使用L-精胺酸1.042g以外,其餘與實施例2同樣地進行而調製溶解液後,以60℃乾燥10小時,得到23.042g之L-抗壞血酸2-糖苷粉末組成物。 The solution was prepared in the same manner as in Example 2 except that 1.042 g of L-arginine was used, and then dried at 60 ° C for 10 hours to obtain 23.04 g of an L-ascorbic acid 2-glycoside powder composition.

(實施例5) (Example 5)

除了取代L-精胺酸而使用氫氧化鉀(東京應化工業股份有限公司,以下皆同)0.39g以外,其餘與實施例1同樣地進行而調製溶解液後,以60℃乾燥10小時,得到22.39g之L-抗壞血酸2-糖苷粉末組成物。 The solution was prepared in the same manner as in Example 1 except that 0.39 g of potassium hydroxide (Tokyo Chemical Industry Co., Ltd., the following is the same) was used instead of L-arginine, and then dried at 60 ° C for 10 hours. 22.39 g of an L-ascorbic acid 2-glycoside powder composition was obtained.

(實施例6) (Example 6)

除了取代L-精胺酸而使用氫氧化鉀0.39g以外,其餘與實施例2同樣地進行而調製溶解液後,以60℃乾燥10小時,得到22.39g之L-抗壞血酸2-糖苷粉末組成物。 The solution was prepared in the same manner as in Example 2 except that 0.39 g of potassium hydroxide was used instead of L-arginine, and then dried at 60 ° C for 10 hours to obtain 22.39 g of L-ascorbic acid 2-glycoside powder composition. .

(實施例7) (Example 7)

除了取代L-精胺酸而使用2-胺基-2-甲基-1-丙醇(ANGUS Chemical Company,以下皆同)0.542g以外,其餘與實施例1同樣地進行而調製溶解液後,以60℃乾燥10小時,得到22.542g之L-抗壞血酸2-糖苷粉末組成物。 The solution was prepared in the same manner as in Example 1 except that 0.5-g of 2-amino-2-methyl-1-propanol (ANGUS Chemical Company, the same applies hereinafter) was used instead of L-arginine. After drying at 60 ° C for 10 hours, 22.542 g of an L-ascorbic acid 2-glycoside powder composition was obtained.

(實施例8) (Example 8)

除了取代L-精胺酸而使用2-胺基-2-甲基-1-丙醇0.542g以外,其餘與實施例2同樣地進行而調製溶解液後,以60℃乾燥10小時,得到22.542g之L-抗壞血酸2-糖苷粉末組成 物。 The solution was prepared in the same manner as in Example 2 except that 0.54 g of 2-amino-2-methyl-1-propanol was used instead of L-arginine, and then dried at 60 ° C for 10 hours to obtain 22.542. g-L-ascorbic acid 2-glycoside powder composition Things.

(比較例1) (Comparative Example 1)

加入L-抗壞血酸2-糖苷2g、檸檬酸酐0.3g、甲基聚矽氧烷處理滑石20g,以混合器均勻混合,得到粉末狀之組成物22.3g。 2 g of L-ascorbic acid 2-glycoside, 0.3 g of citric acid anhydride, and 20 g of talc were treated with methyl polyoxyalkylene, and uniformly mixed by a mixer to obtain 22.3 g of a powdery composition.

(比較例2) (Comparative Example 2)

加入L-抗壞血酸2-糖苷2g、L-精胺酸1.032g、甲基聚矽氧烷處理滑石20g,以混合器均勻混合,得到粉末狀之組成物23.032g。 2 g of L-ascorbic acid 2-glycoside, 1.032 g of L-arginine, and 20 g of talc were treated with methyl polyoxyalkylene, and uniformly mixed by a mixer to obtain 23.032 g of a powdery composition.

[評價方法] [Evaluation method]

針對實施例1~8所製造之L-抗壞血酸2-糖苷粉末組成物及比較例1~2所製造之粉末狀組成物,依下述方法,測定(1)L-抗壞血酸2-糖苷(AA2G)殘存率及(2)Ph。結果示於表1。 With respect to the L-ascorbic acid 2-glycoside powder composition produced in Examples 1 to 8 and the powdery composition produced in Comparative Examples 1 and 2, (1) L-ascorbic acid 2-glycoside (AA2G) was measured by the following method. Residual rate and (2) Ph. The results are shown in Table 1.

(1)AA2G殘存率之測定 (1) Determination of the residual rate of AA2G

將粉末5g裝入塑膠容器中並依關蓋之狀態於40℃×75%RH之恆溫槽保存,求取1個月後、3個月後之AA2G殘存率。殘存率係以HPLC法所測定。測定係參考食安基發第0513003號之測定法,使用十八基矽基化二氧化矽凝膠(島津製作所股份有限公司)及光二極管陣列檢測器(島津製作所股份有限公司)所進行。 5 g of the powder was placed in a plastic container and stored in a thermostat bath at 40 ° C × 75% RH according to the state of the closed lid, and the residual ratio of AA2G after one month and three months was obtained. The residual ratio was measured by HPLC method. The measurement method was carried out by using the measurement method of the food-based ketone hair No. 0513003, using an octadecyl thiolated cerium oxide gel (Shimadzu Corporation) and a photodiode array detector (Shimadzu Corporation).

(2)pH之測定 (2) Determination of pH

實施例1~8係測定製造中之將L-抗壞血酸2-糖苷與pH 調整劑溶解於精製水中之溶液的pH(25℃)。又,比較例1~2係測定於精製水10mL中加入製造後之組成物1g並攪拌後的水溶液的pH(25℃)。又,pH計係使用堀場製作所股份有限公司製(pH計F-53)。 Examples 1-8 are used to measure L-ascorbic acid 2-glycoside and pH in the manufacture. The pH of the solution in which the regulator was dissolved in the purified water (25 ° C). Further, in Comparative Examples 1 and 2, the pH (25 ° C) of an aqueous solution obtained by adding 1 g of the composition after production to 10 mL of purified water was measured. Further, the pH meter was manufactured by Horiba, Ltd. (pH meter F-53).

由表1,比較例1及2的組成物確認到經時性之AA2G的含量降低,於保存3個月後殘存率降低至約70%。 From the compositions of Table 1 and Comparative Examples 1 and 2, it was confirmed that the content of the AA2G with time was lowered, and the residual ratio was lowered to about 70% after storage for 3 months.

另一方面,實施例1~8之L-抗壞血酸2-糖苷粉末組成物係即使於保存3個月後仍確認到AA2G之高穩定性。尤其是使用了疏水處理之粉體的實施例2~4、6及8,AA2G殘存率特別高。 On the other hand, the L-ascorbic acid 2-glycoside powder compositions of Examples 1 to 8 confirmed the high stability of AA2G even after storage for 3 months. In particular, in Examples 2 to 4, 6 and 8 in which the hydrophobically treated powder was used, the residual ratio of AA2G was particularly high.

(實施例9)(美白用身體粉) (Example 9) (whitening body powder)

將L-抗壞血酸2-糖苷20g、L-精胺酸10.32g於50℃混合、溶解於精製水20g中。接著將甲基聚矽氧烷處理滑石200g添加至先前之溶解液並均勻混合後,以60℃乾燥10小時,得到230.32g之粉末組成物。 20 g of L-ascorbic acid 2-glycoside and 10.32 g of L-arginine were mixed at 50 ° C and dissolved in 20 g of purified water. Next, 200 g of methyl polyoxyalkylene-treated talc was added to the previous solution and uniformly mixed, and then dried at 60 ° C for 10 hours to obtain 230.32 g of a powder composition.

將上述所得之粉末組成物、甲基聚矽氧烷處理低溫燒成氧化鋅200g、甲基氫聚矽氧烷處理微粒子氧化鈦200g、甲基聚矽氧烷處理絹雲母92.68g、甲基聚矽氧烷處理滑石100g、對氧基苯甲酸甲酯3g、及甘草酸二鉀1g以混合器均勻混合後,以錘磨進行粉碎。其後,加入雲母鈦170g、鐵丹被覆雲母鈦3g,以混合器均勻混合,得到美白用身體粉1,000g。 The powder composition obtained above, methyl polyoxyalkylene treatment, low-temperature sintering of zinc oxide 200 g, methyl hydrogen polyoxymethane treatment of fine particle titanium oxide 200 g, methyl polyoxyalkylene treatment sericite 92.68 g, methyl poly 100 g of talc-treated talc, 3 g of methyl p-oxybenzoate, and 1 g of dipotassium glycyrrhizinate were uniformly mixed in a mixer, and then pulverized by hammer milling. Thereafter, 170 g of mica titanium and 3 g of iron-coated mica titanium were added, and uniformly mixed by a mixer to obtain 1,000 g of whitening body powder.

[評價方法] [Evaluation method]

針對實施例9所製造之粉末化妝料,依下述方法測定(1)AA2G殘存率及(2)pH。結果示於表2。 With respect to the powder cosmetic produced in Example 9, (1) AA2G residual ratio and (2) pH were measured by the following methods. The results are shown in Table 2.

(1)AA2G殘存率之測定 (1) Determination of the residual rate of AA2G

將粉末化妝料5g裝入塑膠容器中並依關蓋之狀態於 40℃×75%RH之恆溫槽保存,求取1個月後、3個月後、6個月後之AA2G殘存率。殘存率係與上述同樣地依HPLC法所測定。 Put 5g of powder cosmetic into a plastic container and in the state of closing it The temperature was kept at 40 ° C × 75% RH, and the residual rate of AA2G was obtained after 1 month, 3 months, and 6 months. The residual ratio was measured by the HPLC method in the same manner as above.

(2)pH之測定 (2) Determination of pH

測定製造中之將L-抗壞血酸2-糖苷與L-精胺酸溶解於精製水中之溶液的pH(25℃),與於精製水10mL中加入製造後之粉末化妝料1g並攪拌後的水溶液的pH(25℃)。又,pH計係使用堀場製作所股份有限公司製(pH計F-53)。 The pH (25 ° C) of a solution in which L-ascorbic acid 2-glycoside and L-arginine were dissolved in purified water in the production was measured, and 1 g of the powder cosmetic after the production was added to 10 mL of the purified water, and the aqueous solution was stirred. pH (25 ° C). Further, the pH meter was manufactured by Horiba, Ltd. (pH meter F-53).

由表2結果,實施例9之粉末化妝料係於保存6個月後仍保持殘存率90%以上,確認到AA2G之高穩定性。 As a result of Table 2, the powder cosmetic of Example 9 retained the residual ratio of 90% or more after 6 months of storage, and confirmed the high stability of AA2G.

Claims (7)

一種粉末化妝料,係含有於水系溶媒中溶解L-抗壞血酸2-糖苷與pH調整劑,接著將溶解液乾燥而獲得之L-抗壞血酸2-糖苷粉末組成物。 A powder cosmetic comprising a L-ascorbic acid 2-glycoside powder composition obtained by dissolving L-ascorbic acid 2-glycoside in a water-based solvent and a pH adjuster, followed by drying the solution. 如申請專利範圍第1項之粉末化妝料,其中,L-抗壞血酸2-糖苷粉末組成物係將已溶解L-抗壞血酸2-糖苷與pH調整劑的溶解液,進一步分散於粉體中後再進行乾燥者。 The powder cosmetic according to the first aspect of the invention, wherein the L-ascorbic acid 2-glycoside powder composition further dissolves the dissolved solution of the L-ascorbic acid 2-glycoside and the pH adjuster in the powder, and then performs Dryer. 如申請專利範圍第2項之粉末化妝料,其中,粉體為經疏水處理的粉體。 A powder cosmetic according to claim 2, wherein the powder is a hydrophobically treated powder. 如申請專利範圍第1至3項中任一項之粉末化妝料,其中,pH調整劑為選自氫氧化鉀、2-胺基-2-甲基-1-丙醇及精胺酸之1種或2種以上。 The powder cosmetic according to any one of claims 1 to 3, wherein the pH adjusting agent is selected from the group consisting of potassium hydroxide, 2-amino-2-methyl-1-propanol and arginine 1 Kind or more than two. 如申請專利範圍第1至3項中任一項之粉末化妝料,其中,水系溶媒為水。 The powder cosmetic according to any one of claims 1 to 3, wherein the aqueous solvent is water. 一種粉末化妝料之製造方法,其特徵為含有:將L-抗壞血酸2-糖苷及pH調整劑溶解於水系溶媒中的步驟;與藉由將所得之溶解液乾燥,而製造L-抗壞血酸2-糖苷粉末組成物的步驟。 A method for producing a powder cosmetic comprising: a step of dissolving L-ascorbic acid 2-glycoside and a pH adjuster in an aqueous solvent; and drying the obtained solution to produce L-ascorbic acid 2-glycoside The step of the powder composition. 一種粉末化妝料之製造方法,其特徵為含有:將L-抗壞血酸2-糖苷及pH調整劑溶解於水系溶媒中的步驟;將所得溶解液分散於粉體中的步驟;與藉由將所得之含有溶解液之粉體乾燥,而製造L-抗壞血酸2-糖苷粉末組成物的步驟。 A method for producing a powder cosmetic, comprising: a step of dissolving L-ascorbic acid 2-glycoside and a pH adjuster in an aqueous solvent; and dispersing the obtained solution in the powder; and The step of producing a powder of L-ascorbic acid 2-glycoside powder by drying the powder containing the solution.
TW101140267A 2011-10-31 2012-10-31 Powdery cosmetic TW201318641A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011238859 2011-10-31

Publications (1)

Publication Number Publication Date
TW201318641A true TW201318641A (en) 2013-05-16

Family

ID=48192050

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101140267A TW201318641A (en) 2011-10-31 2012-10-31 Powdery cosmetic

Country Status (3)

Country Link
JP (1) JPWO2013065705A1 (en)
TW (1) TW201318641A (en)
WO (1) WO2013065705A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2016056648A1 (en) * 2014-10-10 2017-08-03 株式会社林原 Method for stabilizing 2-O-α-D-glucosyl-L-ascorbic acid in acidic aqueous media
EP3928626A4 (en) * 2019-02-20 2022-12-07 Hayashibara Co., Ltd. Crystal of potassium salt of 2-o-alpha-d-glucosyl-l-ascorbic acid and production method therefor
WO2023079779A1 (en) * 2021-11-07 2023-05-11 株式会社ドクターズチョイス Compound containing ascorbic acid derivative
CN115368484B (en) * 2022-09-28 2023-11-24 水羊化妆品制造有限公司 Preparation method of peach gum polysaccharide, application of peach gum polysaccharide and cosmetics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3476130B2 (en) * 1999-12-17 2003-12-10 西川ゴム工業株式会社 Food formulation and food manufacturing
US8841261B2 (en) * 2004-03-17 2014-09-23 Hayashibara Co., Ltd. Functional powdery product
CN1981737A (en) * 2005-12-15 2007-06-20 台盐实业股份有限公司 Soluble cosmetic composition and its production
US8343951B2 (en) * 2006-02-22 2013-01-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor
DE102006038629A1 (en) * 2006-08-17 2008-02-21 Dr. Suwelack Skin & Health Care Ag Stabilized active ingredient composition

Also Published As

Publication number Publication date
WO2013065705A1 (en) 2013-05-10
JPWO2013065705A1 (en) 2015-04-02

Similar Documents

Publication Publication Date Title
JP7011243B2 (en) Transdermal absorption composition containing a lipid peptide type compound
JP6857359B2 (en) New sugar derivative gelling agent
JP2000119156A (en) Skin lotion
JP2000136122A (en) Skin lotion
TW201318641A (en) Powdery cosmetic
JP2008239545A (en) Elastase deactivator
WO2013125708A1 (en) Topical skin preparation and healthy skin cell activation agent
JP2001031580A (en) Preparation for external use for skin
JP6757130B2 (en) A composition having an azulene compound, and a discoloration inhibitor and a discoloration prevention method for the azulene compound.
JP2008100991A (en) Aqueous preparation having stabilized carotenoid
JP2002275018A (en) Skin care preparation
JP3513871B2 (en) Skin whitening external preparation
JP2010150173A (en) Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation
JP6834178B2 (en) Gel-like composition
JP2009203190A (en) Cell activator and anti-aging skin preparation for external use
JP2010043041A (en) Cosmetic composition
JP2006193491A (en) WHITENING AGENT, PIGMENTATION CONTROL AGENT, alpha-MSH INHIBITOR AND EXTERNAL APPLICATION DRUG FOR SKIN
JP4444073B2 (en) Cosmetics
JP2010018584A (en) COSMETIC COMPOSITION CONTAINING POLY-gamma-L-GLUTAMIC ACID AND/OR ITS SALT
JP2009256326A (en) Skin whitening preparation, and skincare preparation
JP2010120898A (en) Cosmetic composition
JP2003335624A (en) Method for suppressing discoloration of tannin- containing composition and the composition
JP2015205862A (en) Cosmetic and aging odor inhibitor
JP6752551B2 (en) Tyrosinase activity inhibitor and topical skin preparation
JP6051047B2 (en) Skin external preparation for hair